首页> 外文OA文献 >Chemotherapy versus Hypomethylating Agents for the Treatment of Relapsed Acute Myeloid Leukemia and Myelodysplastic Syndrome after Allogeneic Stem Cell Transplant

【2h】

Chemotherapy versus Hypomethylating Agents for the Treatment of Relapsed Acute Myeloid Leukemia and Myelodysplastic Syndrome after Allogeneic Stem Cell Transplant

机译：化疗与低甲基化剂治疗同种异体干细胞移植后的复发急性髓性白血病和骨髓增生术综合征

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Ibraheem H. Motabi; Armin Ghobadi; Jingxia Liu; Mark Schroeder; Camille N. Abboud; Amanda F. Cashen; Keith E. Stockler-Goldstein; Geoffrey L. Uy; Ravi Vij; Peter Westervelt; John F. DiPersio;
展开▼
作者单位

展开▼
年度 2016
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Chemotherapy versus Hypomethylating Agents for the Treatment of Relapsed Acute Myeloid Leukemia and Myelodysplastic Syndrome after Allogeneic Stem Cell Transplant [J] . Motabi Ibraheem H., Ghobadi Armin, Liu Jingxia, Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2016,第7期

机译：化学疗法与次甲基化剂治疗同种异体干细胞移植后复发的急性髓细胞性白血病和骨髓增生异常综合症
2. One plus one does not always equal two, especially with regard to hypomethylating agents: the question of synergy of azacitidine and lenalidomide for treatment of relapsed acute myeloid leukemia and myelodysplastic syndromes post allogeneic hematopoietic stem cell transplant [J] . Jan Philipp Bewersdorf, Maximilian Stahl, Amer M. Zeidan Expert review of hematology . 2019,第7a12期

机译：一个加一个并不总是等于两种，特别是关于低甲基化试剂：偶氮辛辛胺的协同作用问题和世民作用的急性髓性白血病和骨髓增强综合征后异种造血干细胞移植后
3. Salvage Therapy with Hypomethylating Agents (HMA) and/or Lenalidomide (len) for Patients with Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia (AML) Relapse Following Allogeneic Stem Cell Transplantation (allo-SCT) [J] . Singh Meenu, Dhakal Binod, Shrestha Anuj, Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2016,第3Suppla1期

机译：同种异体干细胞移植（allo-SCT）后发生骨髓增生异常综合症（MDS）或急性骨髓性白血病（AML）复发的患者，用次甲基化剂（HMA）和/或来那度胺（len）进行挽救疗法
4. Ras gene mutation in acute myeloid leukemia and Myelodysplastic syndromes: a meta-analysis of its occurrence and prognostic relevance [C] . Cheng Jingru, Wang Peng, Zhang Tai, International Conference on Advanced Materials and Computer Science . 2016

机译：RAS基因突变在急性髓性白血病和髓细胞增强综合征中：荟萃分析其发生和预后相关性
5. Myelodysplastic Syndrome Progression to Acute Myeloid Leukemia at the Stem Cell Level [D] . Chen, Jiahao. 2018

机译：在干细胞水平上骨髓增生异常综合征进展为急性髓细胞性白血病
6. Value of allogeneic versus autologous stem cell transplantation and chemotherapy in patients with myelodysplastic syndromes and secondary acute myeloid leukemia. Final results of a prospective randomized European Intergroup Trial [O] . Theo de Witte, Anne Hagemeijer, Stefan Suciu, 2010

机译：同种异体与自体干细胞移植和化疗在骨髓增生异常综合症和继发性急性髓细胞白血病患者中的价值。欧洲前瞻性随机小组间试验的最终结果
7. The Role of Hypomethylating Agents Prior to Allogeneic Hematopoietic Stem Cells Transplantation in Acute Myeloid Leukemia and Myelodysplastic Syndrome [O] . VN Ovechkina, SN Bondarenko1, EV Morozova, 2017

机译：低甲基化试剂在同种异体造血干细胞移植中的作用急性髓性白血病和髓细胞增强综合征

Chemotherapy versus Hypomethylating Agents for the Treatment of Relapsed Acute Myeloid Leukemia and Myelodysplastic Syndrome after Allogeneic Stem Cell Transplant

著录项

引文网络

相似文献

相关主题

期刊订阅